Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
about
Copper phenotype in Alzheimer's disease: dissecting the pathwayIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseNumerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic SynapsesAltered transition metal homeostasis in Niemann-Pick disease, type C1.Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoParadigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients.P2X7 receptor-mediated scavenger activity of mononuclear phagocytes toward non-opsonized particles and apoptotic cells is inhibited by serum glycoproteins but remains active in cerebrospinal fluid.Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's diseaseA low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.Copper in Alzheimer's disease: too much or too little?Oxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling.In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution.Orchestration of dynamic copper navigation - new and missing pieces.Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studiesReciprocal modulation of Aβ42 aggregation by copper and homocysteine.Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease.Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.
P2860
Q28294380-46F400DD-4CA3-4A59-A014-FA0801E3AC00Q28743561-B953E4CA-5406-4BFA-87EB-FBCB28C10ABBQ28818161-23D22FB4-5940-4B82-8012-582A225327F4Q34262544-CC844585-309E-4288-86E5-11C6D6055C0CQ34639246-CDA62925-D90D-49B4-80C0-DB8D9198CFFAQ35226905-898D6085-C741-4ADF-8D48-C1DDE0966509Q36006774-1180CDBB-9C5A-42A5-B7D4-F6A52B009E30Q37080419-9F7AFCA1-019F-41D3-BFAA-D348089A8CA6Q37258755-66278F98-DD6F-46F1-B385-2162D8946D32Q37283515-4BB95C48-65E9-4D43-91DB-C42DD616F197Q37464172-F6A658AF-A72E-4D35-A143-EE40C23435E6Q37563576-38C6A1C4-1763-4366-A11A-F6B56C13F64BQ39301195-6BDDADE7-8B32-4BE9-A187-64193D975653Q39420445-15E009E2-4299-4BC9-A299-C083E3708B41Q40032173-03170BE5-AD27-4911-BEEB-B08938F654ECQ41339641-56793A1E-8147-44D4-B59F-7E2F62F39816Q41870787-E4018BD7-C079-4A77-A93B-36F5D5603EF1Q42423799-507825BA-6E8F-405B-9B0B-6FCBA78F937CQ42791835-89F72F08-2F0D-4F97-B4BF-200198260342Q44239135-595B351E-EFAD-443B-B07C-B3B45C258E3BQ45898364-55BF6431-9F55-4AEF-8E6D-0ADF5CB63673Q46458603-98F3D1C9-4BE5-4469-BC55-6E51CCE8EB3DQ51325096-0299020C-5D8F-4F21-BD38-B78A60B7FD98
P2860
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@en
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@nl
type
label
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@en
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@nl
prefLabel
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@en
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@nl
P2093
P50
P1433
P1476
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
@en
P2093
Concetta R Capo
Lilia Calabrese
Luisa Rossi
Paolo Maria Rossini
P2860
P2888
P304
P356
10.1007/S10534-007-9125-4
P577
2007-11-30T00:00:00Z